Meiji Yasuda Asset Management Co Ltd. raised its position in shares of Centene Co. (NYSE:CNC – Free Report) by 21.2% during the second quarter, HoldingsChannel.com reports. The fund owned 9,318 shares of the company’s stock after buying an additional 1,627 shares during the quarter. Meiji Yasuda Asset Management Co Ltd.’s holdings in Centene were worth $618,000 at the end of the most recent quarter.
Several other hedge funds have also recently made changes to their positions in CNC. Rise Advisors LLC bought a new stake in Centene in the first quarter worth approximately $25,000. WR Wealth Planners LLC increased its stake in shares of Centene by 41.4% in the 2nd quarter. WR Wealth Planners LLC now owns 468 shares of the company’s stock valued at $31,000 after acquiring an additional 137 shares in the last quarter. Chris Bulman Inc acquired a new position in shares of Centene during the 2nd quarter valued at $33,000. Riverview Trust Co grew its holdings in Centene by 154.6% in the second quarter. Riverview Trust Co now owns 527 shares of the company’s stock worth $35,000 after purchasing an additional 320 shares during the period. Finally, Thurston Springer Miller Herd & Titak Inc. bought a new stake in Centene in the second quarter valued at $36,000. 93.63% of the stock is owned by institutional investors.
Centene Stock Performance
NYSE:CNC opened at $75.63 on Friday. Centene Co. has a 52 week low of $63.45 and a 52 week high of $81.42. The firm has a 50-day moving average price of $74.48 and a two-hundred day moving average price of $73.51. The firm has a market cap of $40.36 billion, a price-to-earnings ratio of 15.04, a price-to-earnings-growth ratio of 0.99 and a beta of 0.48. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.17 and a current ratio of 1.17.
Analysts Set New Price Targets
Several analysts have recently commented on the company. JPMorgan Chase & Co. reduced their target price on Centene from $85.00 to $80.00 and set a “neutral” rating for the company in a research note on Wednesday, July 10th. Truist Financial decreased their price objective on Centene from $92.00 to $89.00 and set a “buy” rating for the company in a report on Monday, July 15th. Jefferies Financial Group downgraded shares of Centene from a “buy” rating to a “hold” rating and reduced their price target for the company from $83.00 to $69.00 in a research report on Wednesday, July 24th. Robert W. Baird began coverage on shares of Centene in a report on Thursday, May 30th. They set a “neutral” rating and a $83.00 price objective on the stock. Finally, Oppenheimer reduced their price objective on shares of Centene from $110.00 to $95.00 and set an “outperform” rating for the company in a report on Monday, July 29th. Seven research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, Centene currently has a consensus rating of “Moderate Buy” and a consensus target price of $85.58.
View Our Latest Report on Centene
Centene Company Profile
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.
Read More
- Five stocks we like better than Centene
- 3 Fintech Stocks With Good 2021 Prospects
- Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut
- What are earnings reports?
- FedEx Stock Dips: Another Reason to Fear Recession Is Near
- 3 Best Fintech Stocks for a Portfolio Boost
- The Half-Penny Revolution: Will SEC’s Reform Benefit Investors?
Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Co. (NYSE:CNC – Free Report).
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.